Advertisement

MoU No More: Sahasra’s Surprise Exit from Taiwan Deal Leaves Industry Guessing


Updated: July 15, 2025 16:52

Image Source : Upstox

Stay Ahead – Explore Now! Aurobindo Pharma’s CuraTeQ Hits Major Milestone With Denosumab Biosimilar Phase 3 Success

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement